Daniel O Scharfstein (D Scharfstein, Daniel Scharfstein)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 12

Top Topics

Respiratory Syndrome Coronavirus

Silver Nanoparticles

Top Venues

Statistics in medicine

The Journal of bone and joint surgery. American volume

This page only lists publications with an associated author ORCID identifier.

Publications

Leon Di Stefano, Elizabeth L Ogburn, Malathi Ram, Daniel O Scharfstein, Tianjing Li, Preeti Khanal, Sheriza N Baksh, Nichol McBee, Joshua Gruber, Marianne R Gildea, Megan R Clark, Neil A Goldenberg, Yussef Bennani, Samuel M Brown, Whitney R Buckel, Meredith E Clement, Mark J Mulligan, Jane A O'Halloran, Adriana M Rauseo, Wesley H Self, Matthew W Semler, Todd B Seto, Jason E Stout, Robert J Ulrich, Jennifer Victory, Barbara E Bierer, Daniel F Hanley, Daniel A Freilich, null null
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis. PloS one 17 (9) (2022)
Joseph F Levy, Lisa Reider, Daniel O Scharfstein, Andrew N Pollak, Jamieson M O'Marr, Reza Firoozabadi, Kristin R Archer, Joshua L Gary, Robert V O'Toole, Renan C Castillo, Stephen M Quinnan, Laurence B Kempton, Clifford B Jones, Michael J Bosse, Ellen J MacKenzie, null null
The 1-Year Economic Impact of Work Productivity Loss Following Severe Lower Extremity Trauma. The Journal of bone and joint surgery. American volume (2022)
Isabel R Fulcher, Ilya Shpitser, Vanessa Didelez, Kali Zhou, Daniel O Scharfstein
Discussion on "Causal mediation of semicompeting risks" by Yen-Tsung Huang. Biometrics (2021)
Daniel O Scharfstein, Jon Arni Steingrimsson, Aidan McDermott, Chenguang Wang, Souvik Ray, Aimee Campbell, Edward Nunes, Abigail Matthews
Global sensitivity analysis of randomized trials with nonmonotone missing binary outcomes: Application to studies of substance use disorders. Biometrics (2021)
David C Benkeser, Iván Díaz, Alex Luedtke, Jodi Segal, Daniel O Scharfstein, Michael D Rosenblum
Rejoinder: Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes. Biometrics (2021)
David C Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel O Scharfstein, Michael D Rosenblum
Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes. Biometrics (2020)
Rui Duan, Ming Cao, Yang Ning, Mingfu Zhu, Bin Zhang, Aidan McDermott, Haitao Chu, Xiao-Hua Zhou, Jason H Moore, Joseph G Ibrahim, Daniel O Scharfstein, Yong Chen
Global identifiability of latent class models with applications to diagnostic test accuracy studies: A Gröbner basis approach. Biometrics 76 (1) (2019)
Baldur P Magnusson, Heinz Schmidli, Nicolas Rouyrre, Daniel O Scharfstein
Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence. Statistics in medicine 38 (23) (2019)
Daniel O Scharfstein
A constructive critique of the draft ICH E9 Addendum. Clinical trials (London, England) 16 (4) (2019)
N Lunardon, Daniel O Scharfstein
Comment on 'Small sample GEE estimation of regression parameters for longitudinal data'. Statistics in medicine 36 (22) (2018)
Daniel O Scharfstein, Aidan McDermott
Global sensitivity analysis of clinical trials with missing patient-reported outcomes. Statistical methods in medical research 28 (5) (2018)
Daniel O Scharfstein, Aidan McDermott, Iván Díaz, Marco Carone, Nicola Lunardon, Ibrahim Turkoz
Global sensitivity analysis for repeated measures studies with informative drop-out: A semi-parametric approach. Biometrics 74 (1) (2017)